Action and function of Faecalibacterium prausnitzii in health and disease

Rajilić-Stojanović, 2013, Long-term monitoring of the human intestinal microbiota composition, Environ Microbiol, 15, 1146, 10.1111/1462-2920.12023

Palm, 2015, Immune-microbiota interactions in health and disease, Clin Immunol, 159, 122, 10.1016/j.clim.2015.05.014

Chen, 2015, Interaction between microbes and host intestinal health: modulation by dietary nutrients and gutbrain-endocrine-immune axis, Curr Protein Pept Sci, 16, 592, 10.2174/1389203716666150630135720

De Filippo, 2010, Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa, Proc Natl Acad Sci U. S. A, 107, 14691, 10.1073/pnas.1005963107

Andoh, 2012, Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease, J Gastroenterol, 47, 1298, 10.1007/s00535-012-0605-0

Mika, 2015, Exercise is more effective at altering gut microbial composition and producing stable changes in lean mass in juvenile versus adult male F344 rats, PLoS One, 10, 10.1371/journal.pone.0125889

Tomas, 2013, Primocolonization is associated with colonic epithelial maturation during conventionalization, FASEB J, 27, 645, 10.1096/fj.12-216861

Tamboli, 2004, Dysbiosis in inflammatory bowel disease, Gut, 53, 1, 10.1136/gut.53.1.1

Konstantinov, 2013, Functional genomic analyses of the gut microbiota for CRC screening, Nat Rev Gastroenterol Hepatol, 10, 741, 10.1038/nrgastro.2013.178

Moos, 2016, Microbiota and Neurological disorders: a gut Feeling, Biores Open Access, 5, 137, 10.1089/biores.2016.0010

Turnbaugh, 2006, An obesity- associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414

Mazmanian, 2008, Capsular polysaccharides of symbiotic bacteria modulate immune responses during experimental colitis, J Pediatr Gastroenterol Nutr, 46, E11, 10.1097/01.mpg.0000313824.70971.a7

Sokol, 2008, Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients, Proc Natl Acad Sci U. S. A, 105, 16731, 10.1073/pnas.0804812105

Swidsinski, 2008, Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora, Inflamm Bowel Dis, 14, 147, 10.1002/ibd.20330

Marteau, 2009, Bacterial flora in inflammatory bowel disease, Dig Dis, 27, 99, 10.1159/000268128

Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature, 457, 480, 10.1038/nature07540

Lakhan, 2010, Gut inflammation in chronic fatigue syndrome, Nutr Metab (Lond), 12, 79, 10.1186/1743-7075-7-79

Rajilić-Stojanović, 2011, Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome, Gastroenterology, 141, 1792, 10.1053/j.gastro.2011.07.043

Sobhani, 2011, Microbial dysbiosis in colorectal cancer (CRC) patients, PLoS One, 6, e16393, 10.1371/journal.pone.0016393

Lepage, 2013, A metagenomic insight into our gut's microbiome, Gut, 62, 146, 10.1136/gutjnl-2011-301805

Castellarin, 2012, Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma, Genome Res, 22, 299, 10.1101/gr.126516.111

Kostic, 2012, Genomic analysis identifies association of Fusobacterium with colorectal carcinoma, Genome Res, 22, 292, 10.1101/gr.126573.111

Miquel, 2013, Faecalibacterium prausnitzii and human intestinal health, Curr Opin Microbiol, 16, 255, 10.1016/j.mib.2013.06.003

Jandhyala, 2015, Role of the normal gut microbiota, World J Gastroenterol, 21, 8787, 10.3748/wjg.v21.i29.8787

Gibson, 2015, Antibiotics and the developing infant gut microbiota and resistome, Curr Opin Microbiol, 27, 51, 10.1016/j.mib.2015.07.007

Spanogiannopoulos, 2016, The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism, Nat Rev Microbiol, 14, 273, 10.1038/nrmicro.2016.17

Duncan, 2008, Proposal of a neotype strain (A1-86) for Eubacterium rectale. Request for an opinion, Int J Syst Evol Microbiol, 58, 1735, 10.1099/ijs.0.2008/004580-0

Louis, 2009, Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine, FEMS Microbiol Lett, 294, 1, 10.1111/j.1574-6968.2009.01514.x

Gibson, 1995, Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics, J Nutr, 125, 1401

Scott, 2015, Manipulating the gut microbiota to maintain health and treat disease, Microb Ecol Health Dis, 26

Ramirez-Farias, 2009, Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii, Br J Nutr, 101, 541, 10.1017/S0007114508019880

Duncan, 2002, Growth requirements and fermentation products of fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov, Int J Syst Evol Microbiol, 52, 2141

Miquel, 2014, Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii, Gut Microbes, 5, 146, 10.4161/gmic.27651

Gullón, 2016, Assessment of the prebiotic effect of quinoa and amaranth in the human intestinal ecosystem, Food Funct, 7, 3782, 10.1039/C6FO00924G

Miquel, 2015, Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii, MBio, 6, 10.1128/mBio.00300-15

Murai, 2009, Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis, Nat Immunol, 10, 1178, 10.1038/ni.1791

Sokol, 2009, Low counts of Faecalibacterium prausnitzii in colitis microbiota, Inflamm Bowel Dis, 15, 1183, 10.1002/ibd.20903

Machiels, 2014, A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis, Gut, 63, 1275, 10.1136/gutjnl-2013-304833

Prosberg, 2016, The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta- analysis, Scand J Gastroenterol, 51, 1407, 10.1080/00365521.2016.1216587

Schäffler, 2016, Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study, Int J Colorectal Dis, 31, 961, 10.1007/s00384-016-2548-z

Karlsson, 2013, Gut metagenome in European women with normal, impaired and diabetic glucose control, Nature, 498, 99, 10.1038/nature12198

Gagnière, 2016, Gut microbiota imbalance and colorectal cancer, World J Gastroenterol, 14, 501, 10.3748/wjg.v22.i2.501

Mármol, 2017, Colorectal Carcinoma: A general overview and future perspectives in colorectal cancer, Int J Mol Sci, 18, 10.3390/ijms18010197

Balamurugan, 2008, Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer, J Gastroenterol Hepatol, 23, 1298, 10.1111/j.1440-1746.2008.05490.x

Wei, 2016, Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients' survival? A pilot study on relevant mechanism, Oncotarget, 7, 46158, 10.18632/oncotarget.10064

Eppinga, 2016, Similar Depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in Hidradenitis suppurativa, J Crohns Colitis, 10, 1067, 10.1093/ecco-jcc/jjw070

Koren, 2012, Host remodeling of the gut microbiome and metabolic changes during pregnancy, Cell, 150, 470, 10.1016/j.cell.2012.07.008

Voudoukis, 2014, Multipotent role of platelets in inflammatory bowel diseases: a clinical approa, World J Gastroenterol, 20, 3180, 10.3748/wjg.v20.i12.3180

Yoshida, 2009, Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation, Inflamm Bowel Dis, 15, 1245, 10.1002/ibd.20896

Sartor, 2008, Therapeutic correction of bacterial dysbiosis discovered by molecular techniques, Proc Natl Acad Sci U. S. A, 105, 16413, 10.1073/pnas.0809363105

Semple, 2011, Platelets and the immune continuum, Nat Rev Immunol, 11, 264, 10.1038/nri2956

Iannacone, 2005, Platelets mediate cytotoxic T lymphocyte-induced liver damage, Nat Med, 11, 1167, 10.1038/nm1317

Yeaman, 2014, Platelets: at the nexus of antimicrobial defence, Nat Rev Microbiol, 12, 426, 10.1038/nrmicro3269

Vowinkel, 2007, CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon, Gastroenterology, 132, 955, 10.1053/j.gastro.2006.12.027

Cardona, 2013, Benefits of polyphenols on gut microbiota and implications in human health, J Nutr Biochem, 24, 1415, 10.1016/j.jnutbio.2013.05.001

Espín, 2017, The gut microbiota: a key factor in the therapeutic effects of (poly)phenols, Biochem Pharmacol, 1, 82, 10.1016/j.bcp.2017.04.033

Moreno-Indias, 2016, Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients, Food Funct, 7, 1775, 10.1039/C5FO00886G

Lee, 2017, Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD, Gut, 66, 863, 10.1136/gutjnl-2015-309940

Lee, 2015, Gut microbiota and tacrolimus dosing in kidney transplantation, PLoS One, 10, 10.1371/journal.pone.0122399

Maccaferri, 2010, Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system, J Antimicrob Chemother, 65, 2556, 10.1093/jac/dkq345

Ahmed, 2007, Mucosa- associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples, Appl Environ Microbiol, 73, 7435, 10.1128/AEM.01143-07